Toetsing multicentrisch onderzoek is vereenvoudigd

The CCMO (the Dutch Central Committee on Research Involving Human Subjects) has evaluated the External Review Directive. This new directive for multicentre clinical trials reduces the administrative burden in approving medical research involving human subjects. The number of trial centres approved in the primary decision has increased. However, it still takes quite some time before a study actually starts. The boards of directors of the participating trial centres play an important role in further streamlining the process.

Conflict of interest and financial support: disclosure forms provided by the authors are available along with the full text of this article at www.ntvg.nl, search for A7558; click on ‘Belangenverstrengeling’ (‘Conflict of interest’).